Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 1,297.80 | 643.00 | 771.60 | 855.90 |
Depreciation/ Depletion | 1,568.80 | 1,113.10 | 814.20 | 715.10 |
Non- Cash Items | 1,014.80 | 826.00 | 642.30 | 206.30 |
Changesin Working Capital | -927.50 | -729.60 | -1,017.70 | -651.40 |
Cashfrom Operating Activities | 2,953.90 | 1,852.50 | 1,210.40 | 1,125.90 |
Capital Expenditures | -1,931.60 | -1,726.30 | -1,924.80 | -1,746.30 |
Other Investing Cash Flow Items Total | 927.10 | -12,555.50 | 225.70 | -1,878.40 |
Cashfrom Investing Activities | -1,004.50 | -14,281.80 | -1,699.10 | -3,624.70 |
Financing Cash Flow Items | -847.40 | -485.60 | -109.60 | -116.00 |
Total Cash Dividends Paid | -203.00 | -71.80 | - | 0.00 |
Issuance( Retirement)of Stock Net | 30.70 | 1,201.60 | 42.50 | 797.70 |
Issuance( Retirement)of Debt Net | -1,313.00 | 12,404.50 | 309.20 | 1,882.30 |
Cashfrom Financing Activities | -2,332.70 | 13,048.70 | 242.10 | 2,564.00 |
Foreign Exchange Effects | 2.90 | 21.70 | 3.30 | 7.10 |
Net Changein Cash | -380.40 | 641.10 | -243.30 | 72.30 |
Cash Interest Paid | 847.40 | 485.60 | 109.60 | 116.00 |
Cash Taxes Paid | 292.30 | 228.60 | 262.00 | 193.80 |
Biocon Dividend Biocon Bonus Biocon News Biocon AGM Biocon Rights Biocon Splits Biocon Board Meetings Biocon Key Metrics Biocon Shareholdings Biocon Profit Loss Biocon Balance Sheet Biocon Q1 Results Biocon Q2 Results Biocon Q3 Results Biocon Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks